News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
882,476 Results
Type
Article (88701)
Company Profile (816)
Press Release (792936)
Multimedia
Podcasts (234)
Webinars (35)
Section
Business (233554)
Career Advice (4161)
Deals (39967)
Drug Delivery (176)
Drug Development (91667)
Employer Resources (207)
FDA (18546)
Job Trends (17480)
News (398650)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3049)
Academic (2)
Accelerated approval (54)
Adcomms (40)
Allergies (189)
Alliances (56988)
ALS (228)
Alzheimer's disease (1956)
Antibody-drug conjugate (ADC) (530)
Approvals (18861)
Artificial intelligence (842)
Autoimmune disease (342)
Automation (62)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (242)
Biotechnology (480)
Bladder cancer (210)
Brain cancer (84)
Breast cancer (820)
Cancer (6381)
Cardiovascular disease (545)
Career advice (3595)
Career pathing (51)
CAR-T (370)
CDC (76)
Celiac Disease (3)
Cell therapy (1043)
Cervical cancer (51)
Clinical research (78713)
Collaboration (2312)
Company closure (8)
Compensation (1463)
Complete response letters (103)
COVID-19 (3037)
CRISPR (121)
C-suite (1248)
Cystic fibrosis (166)
Data (8387)
Decentralized trials (3)
Denatured (89)
Depression (190)
Dermatology (94)
Diabetes (650)
Diagnostics (7553)
Digital health (64)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (414)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (311)
Earnings (102461)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138196)
Executive appointments (1178)
FDA (22522)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1891)
Gene editing (267)
Generative AI (87)
Gene therapy (841)
GLP-1 (1260)
Government (5553)
Grass and pollen (8)
Guidances (416)
Healthcare (21206)
HIV (91)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (106)
Immunology and inflammation (351)
Immuno-oncology (111)
Indications (198)
Infectious disease (3427)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (309)
Interviews (820)
IPO (17996)
IRA (61)
Job creations (5206)
Job search strategy (2871)
JPM (73)
Kidney cancer (22)
Labor market (117)
Layoffs (683)
Leadership (52)
Legal (10171)
Liver cancer (110)
Longevity (36)
Lung cancer (840)
Lymphoma (450)
Machine learning (65)
Management (66)
Manufacturing (1186)
MASH (220)
Medical device (15255)
Medtech (15394)
Mergers & acquisitions (23251)
Metabolic disorders (1742)
mRNA (258)
Multiple sclerosis (202)
NASH (24)
Neurodegenerative disease (490)
Neuropsychiatric disorders (126)
Neuroscience (3653)
Neurotech (2)
NextGen: Class of 2026 (7714)
Non-profit (5140)
Now hiring (80)
Obesity (838)
Opinion (371)
Ovarian cancer (238)
Pain (281)
Pancreatic cancer (328)
Parkinson's disease (405)
Partnered (39)
Patents (640)
Patient recruitment (727)
Peanut (67)
People (67877)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24327)
Phase 2 (34192)
Phase 3 (25704)
Pipeline (9342)
Policy (394)
Postmarket research (3559)
Preclinical (10949)
Press Release (72)
Prostate cancer (332)
Psychedelics (68)
Radiopharmaceuticals (365)
Rare diseases (1226)
Real estate (7461)
Recruiting (81)
Regulatory (30247)
Reports (77)
Research institute (2767)
Resumes & cover letters (653)
Rett syndrome (40)
RNA editing (28)
RSV (98)
Schizophrenia (194)
Series A (318)
Series B (229)
Service/supplier (28)
Sickle cell disease (122)
Special edition (32)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4368)
State (2)
Stomach cancer (21)
Supply chain (143)
Tariffs (104)
The Weekly (142)
Vaccines (1290)
Venture capital (128)
Weight loss (576)
Women's health (136)
Worklife (24)
Date
Today (6)
Last 7 days (616)
Last 30 days (3305)
Last 365 days (32905)
2026 (14835)
2025 (33222)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (394)
Arkansas (16)
Asia (52192)
Australia (9179)
California (14112)
Canada (3955)
China (1506)
Colorado (604)
Connecticut (624)
Delaware (433)
Europe (120353)
Florida (2091)
Georgia (461)
Hawaii (4)
Idaho (70)
Illinois (1207)
India (101)
Indiana (653)
Iowa (25)
Japan (575)
Kansas (142)
Kentucky (56)
Louisiana (50)
Maine (89)
Maryland (1714)
Massachusetts (10298)
Michigan (421)
Minnesota (786)
Mississippi (7)
Missouri (162)
Montana (37)
Nebraska (30)
Nevada (152)
New Hampshire (92)
New Jersey (3741)
New Mexico (34)
New York (3704)
North Carolina (1909)
North Dakota (11)
Northern California (7002)
Ohio (438)
Oklahoma (26)
Oregon (55)
Pennsylvania (2794)
Puerto Rico (30)
Rhode Island (53)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5522)
Tennessee (223)
Texas (2291)
United States (50474)
Utah (422)
Vermont (1)
Virginia (357)
Washington D.C. (89)
Washington State (1161)
West Virginia (4)
Wisconsin (157)
Wyoming (2)
There are 882,476 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ALK to present at the Jefferies Global Healthcare Conference in New York
June 1, 2026
·
1 min read
Press Releases
Dizal Announces Phase 3 WU-KONG28 Results: ZEGFROVY® (Sunvozertinib) Outperforms Platinum-Doublet Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer
June 1, 2026
·
7 min read
Obesity
Obesity Davids and Goliaths face off at ADA 2026
The American Diabetes Association’s annual congress will feature a superstar lineup, including weight loss giants Eli Lilly and Novo Nordisk. But several scrappy biotechs will also present obesity candidates with the potential to match—if not outperform—their deep-pocketed competitors.
June 1, 2026
·
8 min read
·
Tristan Manalac
Press Releases
Innogen to Present Phase IIb ENLIGHT Study Results for Efsubaglutide Alfa at the 2026 ADA Scientific Sessions
June 1, 2026
·
3 min read
Obesity
Biohaven looks to obesity to bounce back from run of clinical and regulatory failures
After trial flops in spinal muscular atrophy, depression and bipolar disorder—and a costly rare disease drug rejection—Biohaven is undergoing a reset, recasting its former SMA candidate for obesity.
June 1, 2026
·
5 min read
·
Heather McKenzie
Immuno-oncology
ASCO: Akeso’s VEGF/PD-1 boosts lung cancer survival, relieving pressure on US partner Summit
Analysts, investors and partner Summit Therapeutics had all been keenly awaiting the overall survival update, after previous data from Akeso’s HARMONi-6 trial left them wanting.
May 31, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Theralase(R) Releases Q1 2026 Financial Statements
Theralase(R) Provides an Update on its Phase II Bladder Cancer Clinical Study
May 29, 2026
·
13 min read
Press Releases
Defence Therapeutics Strengthens Its Scientific Advisory Board with the Appointment of Dr. Sarkis Meterissian
May 29, 2026
·
3 min read
Manufacturing
Cracked gaskets and rust-like residues trigger FDA warning letter to Alchymars
FDA inspectors found Alchymars failed to adequately maintain equipment used to make active pharmaceutical ingredients for the U.S. market. Over-the-counter drugmakers GC America and Sato Pharmaceutical also received warning letters.
May 29, 2026
·
2 min read
·
Nick Paul Taylor
Immuno-oncology
Summit’s PD-1/VEGF to take center stage at ASCO, with wide impact for peers
As Summit Therapeutics’ Chinese partner prepares to reveal data for a key trial at ASCO, analysts consider the impact on rivals Merck, Bristol Myers Squibb and BioNTech.
May 29, 2026
·
4 min read
·
Annalee Armstrong
1 of 88,248
Next
